logo

For the Inventor, By the Inventor

Salem, CT, United States of America

Yong Tao

This inventor holds 5 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2004-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Tao. Retrieved from https://idiyas.com/inventor/yong-tao-d5axo5yk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 20.0

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal5 out of 4,490 
 
Pfizer Corporation
 patents

Years Active: 2004-2024

Loading Chart...
5 patents (USPTO):Explore Patents
1. 12116368 - Pyrrolo[2,3-d]pyrimidine tosylate salt, crystalline form thereof and manufacturing process and intermediates thereto (2024-10-15),
2. 7479559 - Benzyl(idene)-lactam derivatives (2009-01-20),
3. 6949652 - Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine (2005-09-27),
4. 6919460 - Processes and intermediates useful in preparing β3-adrenergic receptor agonists (2005-07-19),
5. 6689888 - Processes and intermediates useful in preparing &bgr;3-adrenergic receptor agonists (2004-02-10),

Title: Yong Tao: Innovator in Pharmaceutical Chemistry

Introduction

Yong Tao is a distinguished inventor based in Salem, Connecticut, known for his significant contributions to pharmaceutical chemistry. With a total of five patents to his name, he has made remarkable advancements in the field, particularly in the development of novel compounds and their applications in treating various medical conditions.

Latest Patents

Yong Tao's latest patents include the invention of Pyrrolo[2,3-d]pyrimidine tosylate salt and its crystalline form, along with the manufacturing process and intermediates. This invention discloses a novel p-toluenesulfonic acid salt and a crystalline polymorphic Form 1 of a specific compound, which has potential applications in pharmaceutical compositions. Additionally, he has developed benzyl(idene)-lactam derivatives, which are useful in treating or preventing depression, anxiety, and obsessive-compulsive disorder (OCD). These compounds are designed to have reduced potential for cardiac side effects, making them safer alternatives for patients.

Career Highlights

Yong Tao is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development in pharmaceuticals.

Collaborations

Some of his notable coworkers include Ming Kang and Robert James Chambers, who have worked alongside him on various projects, enhancing the innovative capabilities of their team.

Conclusion

Yong Tao's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the development of new treatments, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…